- Abstract:
- Severe early-onset fetal growth restriction (FGR) is an untreatable condition associated with substantial mortality and morbidity for the fetus and neonate. There has been growing interest in novel therapies such as nitric oxide donors and promotors to improve placental function and outcomes for these high-risk pregnancies. The UK STRIDER trial was designed to test the effectiveness of sildenafil (25 mg three times a day) versus placebo at prolonging gestation in severe early-onset FGR.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
- Files:
-
-
(, 0.0b)
-
- Publisher copy:
- 10.1016/s2352-4642(19)30020-3
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
- Publisher:
- Elsevier Publisher's website
- Journal:
- Lancet Child and Adolescent Health Journal website
- Volume:
- 3
- Issue:
- 3
- Pages:
- e2-e3
- Publication date:
- 2019-01-28
- Acceptance date:
- 2019-01-14
- DOI:
- EISSN:
-
2352-4642
- Pmid:
-
30704877
- Pubs id:
-
977009
- Local pid:
- pubs:977009
- Language:
- English
- Keywords:
- Format:
- Print-Electronic
- Copyright holder:
- Elsevier
- Copyright date:
- 2019
- Rights statement:
- © 2019 Elsevier Ltd. All rights reserved.
- Notes:
- This is the accepted manuscript version of the article. The final version is available online from Elsevier at: https://doi.org/10.1016/S2352-4642(19)30020-3
Journal article
Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction
Actions
Access Document
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record